High-Resolution Analysis of Mononuclear Phagocytes Reveals GPNMB as a Prognostic Marker in Human Colorectal Liver Metastasis.

Cortese N

Cancer Immunol Res. 11(4):405-420. doi: 10.1158/2326-6066.CIR-22-0462

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.

Trono P

J Immunother Cancer. 11(8)doi: 10.1136/jitc-2023-006913

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Castagna L

Bone Marrow Transplant. 2017 Jan 16;52(5):683-688. doi: 10.1038/bmt.2016.348

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Castagna L

Bone Marrow Transplant. 2015 Jan 26;50(4):499-504. doi: 10.1038/bmt.2014.304

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.

Necchi A

Ann Oncol. 2014 Oct 24;26(1):167-172. doi: 10.1093/annonc/mdu485

Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

Lavazza C

Blood. 2010 Jan 14;115(11):2231-40. doi: 10.1182/blood-2009-08-239632

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.

Dodero A

Blood. 2009 Feb 11;113(19):4771-9. doi: 10.1182/blood-2008-10-183723

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.

Magni M

Bone Marrow Transplant. 2008 Oct 27;43(6):509-11. doi: 10.1038/bmt.2008.349

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

Devizzi L

J Clin Oncol. 2008 Oct 14;26(32):5175-82. doi: 10.1200/JCO.2008.16.8294

Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.

Lavazza C

Exp Hematol. 35(6):888-97.